Physician profile
Amanda S Cooper
NPI 1619049459
$1,214.44
in general payments reported to CMS, 2019-2025
9 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $38.33 · 2021: $110 · 2022: $266 · 2023: $284 · 2024: $111 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $742.06 | 2021-2025 | Venclose Maven Catheter |
| Angiodynamics, INC. | $133.00 | 2019 | |
| Penumbra, INC. | $124.55 | 2019 | |
| Allergan, INC. | $64.37 | 2021-2022 | |
| Boston Scientific Corporation | $59.40 | 2023-2025 | Varithena Administration Pack |
| Venclose INC. | $38.33 | 2020 | |
| Medtronic, INC. | $21.74 | 2022 | |
| Cashflow Solutions, LLC | $16.42 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.